CALUMET INC (CLMT) Fundamental Analysis & Valuation

NASDAQ:CLMT • US1314281049

Current stock price

32.78 USD
+0.3 (+0.92%)
At close:
32.78 USD
0 (0%)
After Hours:

This CLMT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. CLMT Profitability Analysis

1.1 Basic Checks

  • In the past year CLMT has reported negative net income.
  • CLMT had a positive operating cash flow in the past year.
  • In the past 5 years CLMT reported 4 times negative net income.
  • The reported operating cash flow has been mixed in the past 5 years: CLMT reported negative operating cash flow in multiple years.
CLMT Yearly Net Income VS EBIT VS OCF VS FCFCLMT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M -400M

1.2 Ratios

  • CLMT's Return On Assets of -1.26% is on the low side compared to the rest of the industry. CLMT is outperformed by 70.81% of its industry peers.
  • The Return On Invested Capital of CLMT (2.32%) is worse than 66.03% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for CLMT is significantly below the industry average of 22.73%.
Industry RankSector Rank
ROA -1.26%
ROE N/A
ROIC 2.32%
ROA(3y)-2.53%
ROA(5y)-5.09%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)5.26%
ROIC(5y)N/A
CLMT Yearly ROA, ROE, ROICCLMT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 -100

1.3 Margins

  • Looking at the Operating Margin, with a value of 1.31%, CLMT is doing worse than 69.86% of the companies in the same industry.
  • CLMT's Operating Margin has declined in the last couple of years.
  • Looking at the Gross Margin, with a value of 5.94%, CLMT is doing worse than 74.16% of the companies in the same industry.
  • CLMT's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 1.31%
PM (TTM) N/A
GM 5.94%
OM growth 3Y-22.92%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.42%
GM growth 5Y-8.51%
CLMT Yearly Profit, Operating, Gross MarginsCLMT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5 10

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. CLMT Health Analysis

2.1 Basic Checks

  • CLMT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, CLMT has more shares outstanding
  • CLMT has more shares outstanding than it did 5 years ago.
  • CLMT has a worse debt/assets ratio than last year.
CLMT Yearly Shares OutstandingCLMT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
CLMT Yearly Total Debt VS Total AssetsCLMT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • Based on the Altman-Z score of 1.29, we must say that CLMT is in the distress zone and has some risk of bankruptcy.
  • CLMT's Altman-Z score of 1.29 is in line compared to the rest of the industry. CLMT outperforms 46.89% of its industry peers.
  • The Debt to FCF ratio of CLMT is 42.45, which is on the high side as it means it would take CLMT, 42.45 years of fcf income to pay off all of its debts.
  • CLMT has a Debt to FCF ratio of 42.45. This is comparable to the rest of the industry: CLMT outperforms 42.58% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 42.45
Altman-Z 1.29
ROIC/WACC0.31
WACC7.48%
CLMT Yearly LT Debt VS Equity VS FCFCLMT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B 1.5B 2B

2.3 Liquidity

  • A Current Ratio of 1.02 indicates that CLMT should not have too much problems paying its short term obligations.
  • CLMT's Current ratio of 1.02 is in line compared to the rest of the industry. CLMT outperforms 42.58% of its industry peers.
  • CLMT has a Quick Ratio of 1.02. This is a bad value and indicates that CLMT is not financially healthy enough and could expect problems in meeting its short term obligations.
  • CLMT has a Quick ratio of 0.56. This is in the lower half of the industry: CLMT underperforms 75.12% of its industry peers.
Industry RankSector Rank
Current Ratio 1.02
Quick Ratio 0.56
CLMT Yearly Current Assets VS Current LiabilitesCLMT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. CLMT Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 57.95% over the past year.
  • The Revenue for CLMT has decreased by -20.37% in the past year. This is quite bad
  • The Revenue has been growing by 12.77% on average over the past years. This is quite good.
EPS 1Y (TTM)57.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%8.51%
Revenue 1Y (TTM)-20.37%
Revenue growth 3Y-4.07%
Revenue growth 5Y12.77%
Sales Q2Q%9.38%

3.2 Future

  • Based on estimates for the next years, CLMT will show a very strong growth in Earnings Per Share. The EPS will grow by 35.80% on average per year.
  • CLMT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.41% yearly.
EPS Next Y35.37%
EPS Next 2Y64.64%
EPS Next 3Y47.84%
EPS Next 5Y35.8%
Revenue Next Year1.44%
Revenue Next 2Y1.25%
Revenue Next 3Y5.28%
Revenue Next 5Y7.41%

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CLMT Yearly Revenue VS EstimatesCLMT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B
CLMT Yearly EPS VS EstimatesCLMT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 2 -2 4 -4

More info and screens

Find the best growth stocksShow best growing peers

1

4. CLMT Valuation Analysis

4.1 Price/Earnings Ratio

  • CLMT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year CLMT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CLMT Price Earnings VS Forward Price EarningsCLMT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CLMT is valued a bit more expensive than 66.99% of the companies in the same industry.
  • CLMT's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 50.26
EV/EBITDA 25.23
CLMT Per share dataCLMT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 30 40

4.3 Compensation for Growth

  • A more expensive valuation may be justified as CLMT's earnings are expected to grow with 47.84% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y64.64%
EPS Next 3Y47.84%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CLMT Dividend Analysis

5.1 Amount

  • No dividends for CLMT!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CLMT Fundamentals: All Metrics, Ratios and Statistics

CALUMET INC

NASDAQ:CLMT (4/23/2026, 8:00:01 PM)

After market: 32.78 0 (0%)

32.78

+0.3 (+0.92%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)02-27
Earnings (Next)05-08
Inst Owners51.71%
Inst Owner Change-0.03%
Ins Owners1.91%
Ins Owner Change0.26%
Market Cap2.84B
Revenue(TTM)4.14B
Net Income(TTM)-33.80M
Analysts78.33
Price Target36.72 (12.02%)
Short Float %8.27%
Short Ratio3.74
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)567.09%
Min EPS beat(2)-12.92%
Max EPS beat(2)1147.11%
EPS beat(4)1
Avg EPS beat(4)95.01%
Min EPS beat(4)-407.62%
Max EPS beat(4)1147.11%
EPS beat(8)4
Avg EPS beat(8)49.37%
EPS beat(12)6
Avg EPS beat(12)143.53%
EPS beat(16)6
Avg EPS beat(16)-326.04%
Revenue beat(2)1
Avg Revenue beat(2)-1.64%
Min Revenue beat(2)-3.74%
Max Revenue beat(2)0.47%
Revenue beat(4)3
Avg Revenue beat(4)3.7%
Min Revenue beat(4)-3.74%
Max Revenue beat(4)9.31%
Revenue beat(8)7
Avg Revenue beat(8)6.19%
Revenue beat(12)10
Avg Revenue beat(12)6.21%
Revenue beat(16)14
Avg Revenue beat(16)8.9%
PT rev (1m)38.46%
PT rev (3m)65.04%
EPS NQ rev (1m)9.28%
EPS NQ rev (3m)37.14%
EPS NY rev (1m)17.26%
EPS NY rev (3m)-2444.43%
Revenue NQ rev (1m)0.74%
Revenue NQ rev (3m)-3.13%
Revenue NY rev (1m)1.7%
Revenue NY rev (3m)3.19%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.69
P/FCF 50.26
P/OCF 26.12
P/B N/A
P/tB N/A
EV/EBITDA 25.23
EPS(TTM)-1.11
EYN/A
EPS(NY)-0.72
Fwd EYN/A
FCF(TTM)0.65
FCFY1.99%
OCF(TTM)1.25
OCFY3.83%
SpS47.67
BVpS-8.44
TBVpS-10.16
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -1.26%
ROE N/A
ROCE 2.93%
ROIC 2.32%
ROICexc 2.48%
ROICexgc 2.72%
OM 1.31%
PM (TTM) N/A
GM 5.94%
FCFM 1.37%
ROA(3y)-2.53%
ROA(5y)-5.09%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)5.26%
ROIC(5y)N/A
ROICexc(3y)5.34%
ROICexc(5y)N/A
ROICexgc(3y)6.05%
ROICexgc(5y)N/A
ROCE(3y)6.66%
ROCE(5y)N/A
ROICexgc growth 3Y-33.5%
ROICexgc growth 5YN/A
ROICexc growth 3Y-31.76%
ROICexc growth 5YN/A
OM growth 3Y-22.92%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.42%
GM growth 5Y-8.51%
F-Score4
Asset Turnover1.54
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 42.45
Debt/EBITDA 10.23
Cap/Depr 35.15%
Cap/Sales 1.26%
Interest Coverage 0.31
Cash Conversion 53.65%
Profit Quality N/A
Current Ratio 1.02
Quick Ratio 0.56
Altman-Z 1.29
F-Score4
WACC7.48%
ROIC/WACC0.31
Cap/Depr(3y)90.59%
Cap/Depr(5y)178.84%
Cap/Sales(3y)3.2%
Cap/Sales(5y)4.73%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)57.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%8.51%
EPS Next Y35.37%
EPS Next 2Y64.64%
EPS Next 3Y47.84%
EPS Next 5Y35.8%
Revenue 1Y (TTM)-20.37%
Revenue growth 3Y-4.07%
Revenue growth 5Y12.77%
Sales Q2Q%9.38%
Revenue Next Year1.44%
Revenue Next 2Y1.25%
Revenue Next 3Y5.28%
Revenue Next 5Y7.41%
EBIT growth 1Y16.81%
EBIT growth 3Y-26.06%
EBIT growth 5YN/A
EBIT Next Year116.73%
EBIT Next 3Y55.37%
EBIT Next 5Y40.09%
FCF growth 1Y145.98%
FCF growth 3YN/A
FCF growth 5Y24.66%
OCF growth 1Y334.7%
OCF growth 3Y2.68%
OCF growth 5Y11.64%

CALUMET INC / CLMT Fundamental Analysis FAQ

What is the ChartMill fundamental rating of CALUMET INC (CLMT) stock?

ChartMill assigns a fundamental rating of 2 / 10 to CLMT.


What is the valuation status for CLMT stock?

ChartMill assigns a valuation rating of 1 / 10 to CALUMET INC (CLMT). This can be considered as Overvalued.


What is the profitability of CLMT stock?

CALUMET INC (CLMT) has a profitability rating of 1 / 10.


What is the financial health of CALUMET INC (CLMT) stock?

The financial health rating of CALUMET INC (CLMT) is 1 / 10.